Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A new twist in targeting malaria parasites.

Harrington M.

Lab Anim (NY). 2013 May;42(5):153. doi: 10.1038/laban.292. No abstract available.

PMID:
23604145
2.

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.

Biagini GA, Fisher N, Shone AE, Mubaraki MA, Srivastava A, Hill A, Antoine T, Warman AJ, Davies J, Pidathala C, Amewu RK, Leung SC, Sharma R, Gibbons P, Hong DW, Pacorel B, Lawrenson AS, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Stocks PA, Nixon GL, Chadwick J, Hemingway J, Delves MJ, Sinden RE, Zeeman AM, Kocken CH, Berry NG, O'Neill PM, Ward SA.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8298-303. doi: 10.1073/pnas.1205651109. Epub 2012 May 7.

3.

Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.

Gama BE, Lacerda MV, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.

Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:159-66.

5.

[What is the value of the combination atovaquone-proguanil for the clinician?].

Delmont J.

Med Trop (Mars). 2002;62(3):232-6. Review. French.

PMID:
12244917
6.

[Mefloquine resistance in Plasmodium falciparum malaria].

Garavelli PL.

Recenti Prog Med. 2003 Jul-Aug;94(7-8):343. Italian. No abstract available.

PMID:
12868243
7.

Chemoresistance in falciparum malaria.

May J, Meyer CG.

Trends Parasitol. 2003 Oct;19(10):432-5; discussion 435-6. Review. No abstract available.

PMID:
14519577
8.

[Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].

Kroeger A.

Rev Panam Salud Publica. 2001 Mar;9(3):202-4. Spanish. No abstract available.

PMID:
11349355
9.

Coping with malaria in the face of resistance.

Winstanley P.

Int J Infect Dis. 2002 Dec;6(4):246-52. Review. No abstract available.

PMID:
12718816
10.

Death from malaria following inappropriate chemoprophylaxis.

Kaye D.

Clin Infect Dis. 2001 Sep 1;33(5):i. No abstract available.

PMID:
11545069
11.
12.

Mapping the spread of malaria drug resistance.

Anderson T.

PLoS Med. 2009 Apr 14;6(4):e1000054. doi: 10.1371/journal.pmed.1000054. Epub 2009 Apr 14. No abstract available.

13.

Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

Leung SC, Gibbons P, Amewu R, Nixon GL, Pidathala C, Hong WD, Pacorel B, Berry NG, Sharma R, Stocks PA, Srivastava A, Shone AE, Charoensutthivarakul S, Taylor L, Berger O, Mbekeani A, Hill A, Fisher NE, Warman AJ, Biagini GA, Ward SA, O'Neill PM.

J Med Chem. 2012 Mar 8;55(5):1844-57. doi: 10.1021/jm201184h. Epub 2012 Feb 24.

14.

Helicases - feasible antimalarial drug target for Plasmodium falciparum.

Tuteja R.

FEBS J. 2007 Sep;274(18):4699-704. Review.

15.

[Drug-resistant malaria].

Mockenhaupt FP, May J, Bienzle U, Meyer CG.

Dtsch Med Wochenschr. 1997 Oct 17;122(42):1293-7. Review. German. No abstract available.

PMID:
9378067
16.

The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.

Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D.

PLoS Med. 2012 Feb;9(2):e1001169. doi: 10.1371/journal.pmed.1001169. Epub 2012 Feb 21.

17.

Antimalarial drug resistance and mortality in falciparum malaria.

White N.

Trop Med Int Health. 1999 Jul;4(7):469-70. No abstract available.

18.

Malaria's drug miracle in danger.

Enserink M.

Science. 2010 May 14;328(5980):844-6. doi: 10.1126/science.328.5980.844. No abstract available.

PMID:
20466917
19.

Empowering malaria vaccination by drug administration.

Sauerwein RW, Bijker EM, Richie TL.

Curr Opin Immunol. 2010 Jun;22(3):367-73. doi: 10.1016/j.coi.2010.04.001. Epub 2010 Apr 29. Review.

PMID:
20434895
20.

Encapsulation of metalloporphyrins and falciparum malaria.

Wiwanitkit S, Wiwanitkit V.

Nanomedicine. 2015 May;11(4):1035. doi: 10.1016/j.nano.2015.01.016. Epub 2015 Feb 10. No abstract available.

PMID:
25678198

Supplemental Content

Support Center